RSS-Feed abonnieren
DOI: 10.1055/s-0043-1777832
An Unusual Cause of Increasing Excessive Daytime Sleepiness in a CPAP-treated Obstructive Sleep Apnea Patient
Funding The authors declare that they have received no funding from agencies in the public, private or non-profit sectors to report the present case.
Abstract
The onset of narcolepsy type 1 (NT1) occurs after 50 years of age in less than 2% of the cases. In older adults, the diagnosis is often delayed due to the presence of neurological degenerative and inflammatory comorbidities and overlapping sleep disorders.
We report the case of a 63-year-old man with a 5-year history of excessive daytime sleepiness (EDS) and a 2-year diagnosis of obstructive sleep apnea syndrome (OSAS), which. OSAS was confirmed by respiratory polygraphy that showed an apnea-hypopnea index (AHI) of 71 events/hour of sleep associated with significant nocturnal hypoxemia (lowest oxygen saturation: 53%), which lead to the initiation of continuous positive airway pressure (CPAP) treatment. Cognitive complaints, unexplained spells of dizziness, and lack of improvement in EDS with CPAP led to further diagnostic investigation of infectious, inflammatory, and neurodegenerative disorders. Low hypocretin levels in the cerebrospinal fluid (CSF) confirmed the diagnosis of NT1, and the patient's symptoms improved with the treatment with pitolisant.
Though exceptional in older adults, NT1 should be suspected in the presence of atypical EDS with neurological complaints, unexplained dizzy spells, or OSAS that resists the CPAP treatment. Low levels of hypocretin in the CSF are highly specific and rule out other neurological and sleep disorders.
Publikationsverlauf
Eingereicht: 11. Januar 2023
Angenommen: 02. August 2023
Artikel online veröffentlicht:
15. Februar 2024
© 2024. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Nevsimalova S, Pisko J, Buskova J. et al. Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol 2013; 260 (03) 767-775 DOI: 10.1007/s00415-012-6702-4.
- 2 Krishnamurthy VB, Nallamothu V, Singareddy R. An interesting case of late age at onset of narcolepsy with cataplexy. J Clin Sleep Med 2014; 10 (02) 203-205 DOI: 10.5664/jcsm.3454.
- 3 Quick AD, Black DN, Attarian HP. New-onset narcolepsy with cataplexy in a geriatric patient. Sleep Med 2006; 7 (06) 533 DOI: 10.1016/j.sleep.2006.05.007.
- 4 Kovalská P, Dostálová S, Machová H, Nytrová P, Maurovich Horvat E, Šonka K. Rare Case of Late-Onset Narcolepsy Type 1. Case Rep Neurol 2020; 12 (03) 428-432 DOI: 10.1159/000510633.
- 5 Ripley B, Overeem S, Fujiki N. et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001; 57 (12) 2253-2258 DOI: 10.1212/wnl.57.12.2253.
- 6 Dauvilliers Y, Baumann CR, Carlander B. et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003; 74 (12) 1667-1673 DOI: 10.1136/jnnp.74.12.1667.
- 7 Rosenberg R, Hirshkowitz M, Rapoport DM, Kryger M. The role of home sleep testing for evaluation of patients with excessive daytime sleepiness: focus on obstructive sleep apnea and narcolepsy. Sleep Med 2019; 56: 80-89 DOI: 10.1016/j.sleep.2019.01.014.